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Background: Severe sepsis is a primary cause of morbidity and mortality in the intensive care unit (ICU). Numerous
biomarkers have been assessed to predict outcome and CRP is widely used. However, the relevance for mortality
risk of the CRP level and the day when it is measured have not been well studied. We aimed to assess whether
initial and/or third dayCRP values are as good predictors of mortality in ICU patients with severe sepsis as other
well-known complex predictors of mortality, i.e., SOFA scores.
Methods: An observational cohort study was performed in a 20-bed respiratory ICU in a chest disease center.
Patients with severe sepsis due to respiratory disease were enrolled in the study. SOFA scores, CRP values on
admission and on the third day of hospital stay, and mortality rate were recorded. ROC curves for SOFA scores and
CRP values were calculated.
Results: The study included 314 ICU patients with sepsis admitted between January 2009 and March 2010. The
mortality rate was 14.2% (n = 45). The area under the curve (AUC) for CRP values and SOFA scores on admission
and on the 3rd day in ICU were calculated as 0.57 (CI: 0.48-0.66); 0.72 (CI: 0.63-0.80); 0.72 (CI: 0.64-0.81); and 0.76 (CI:
0.67-0.86), respectively. Sepsis due to nosocomial infection, a CRP value > 100 mg/L and higher SOFA scores on 3rd
day, were found to be risk factors for mortality (odds ratio [OR]: 3.76, confidence interval [CI]: 1.68-8.40, p < 0.001,
OR: 2.70, CI: 1.41-2.01, p < 0.013, and OR: 1.68, CI: 1.41-2.01, p < 0.0001, respectively).
Conclusions: The risk of sepsis related mortality appears to be increased when the 3rd day CRP value is greater
than 100 mg/dL. Thus, CRP appears to be as valuable a predictor of mortality as the SOFA score.
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For the last decade we have known that, to decrease
ICU mortality, identifying sepsis and quickly implement-
ing its therapyis crucial. The ‘surviving sepsis campaign’
[1] has been implemented in emergency and intensive
care units (ICU) all over the world, with significant
results in sepsis therapy. In the case of patients with sep-
sis, APACHE II [2] is used to predict mortality, and the
sepsis related organ failure assessment (SOFA) [3] is
used to evaluate the response to therapy. However, many* Correspondence: zuhalkarakurt@hotmail.com
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reproduction in any medium, provided the orparameters are required for these scores, and it is not al-
ways practical in the clinical setting. A cheap, they are
rapid, easy method to evaluate therapy response and
predict mortality of patients with severe sepsis requiring
ICU treatment is needed. There are a limited number of
studies that describe baseline C-reactive protein (CRP)
(an inflammatory marker) level, and its changes in re-
sponse to therapy, as a predictor of sepsis mortality. Al-
though one study claims that assessing serum CRP levels
is not an adequate test for predicting sepsis related to
mortality in ICU patients [4], other studies indicate that
CRP is a proper predictor of mortality [5,6]. Recently, Δ
CRP was shown to be a predictor of mortality from sep-
sis in dogs [7]. We aimed to assess whether in patientsLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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and/or third day CRP values could be as good predictors
of mortality as other well known complex predictors of
mortality (i.e., SOFA scores, and APACHE II).
Methods
This study had the local hospital approval of the Internal
Review Board. The study was conducted in a 20-bed re-
spiratory ICU in a chest disease center of a tertiary
teaching hospital. The ICU is a non-surgical, non-obstet-
rical, respiratory unit. Pulmonologists run the ICU and a
pulmonologist is available 24 hours a day. All patients
had acute respiratory failure and the majority of patients
had chronic obstructive pulmonary disease (COPD).
Patients
Between January 1st, 2009 and March 31st, 2010 814
patients with respiratory failure admitted to the ICU
were assessed. Out of these, 314 fulfilled the sepsis cri-
teria [8] for enrollment into the study; they had been in
the ICU for more than three days, and serum CRP had
been assessed. Exclusion criteria were a diagnosis of can-
cer, or rheumatic disease possibly causing a high CRP
level. In all cases the reasons for sepsis were related to
respiratory diseases such as acute exacerbation of
COPD, bronchiectasis, TB sequelae, and pneumonia.
Modified protocol for surviving sepsis
The Early Directed Goal Therapy (EDGT) protocol was
followed as described [1]. Moderate tidal volume [9]; the
protocol was based on providing a tidal volume not
greater than 6 mL/kg per ideal body weight. Moderate
dose steroids [10]: Stress-dose steroid therapy was given
only in cases of septic shock after blood pressure was
identified to be poorly responsive to fluid and vasopressor
therapy (basal cortisol or ACTH stimulation tests were
not obtained as they were not available in our hospital).
Due to the absence of hydrocortisone in our country,
methyl prednisolone was used at a dose of 20 mg tid for
7 days [10] in patients without contra-indications. Glucose
Control protocol [11]; if blood glucose was > 150 mg/dL,
a continuous intravenous insulin infusion was titrated to
maintain blood glucose levels between 110 and 140 mg/dL
(< 150 mg/dL).
Mechanical ventilation
In our unit, if the patient was alert, able to protect the
airway, had no risk of aspiration, and no burn or wound
on the face, non-invasive mechanical ventilation (NIMV)
was the first choice of ventilatory support for hypercap-
nic and hypoxemic respiratory failure [12]. Invasive
mechanical ventilation (IMV) was applied with ICU ven-
tilators (Puritan Bennett 760, Newport and Vela) if the
patient had criteria for intubation such as cardiac arrest,increased work of breathing, respiratory depression,
shock, and altered mental status. Assist control ventila-
tion (A/C), either pressure control or volume control,
was preferred as the initial ventilation mode. In volume
control ventilation, inspiratory flow was set to provide
an airway plateau pressure < 35 cmH2O, and tidal vol-
ume was managed as 6–8 mL/kg ideal body weight.
During mechanical ventilation a sedation protocol was
applied. The Richmond agitation sedation (RAS) scale
was used for infusion and assessment of the daily need
for sedation [13].
Laboratory records
The complete blood count (CBC), serum biochemistry,
and CRP levels of patients were recorded on the first
day in ICU. CBC and blood electrolytes were checked
every day and CRP was checked on the 3rd day of ICU
(control). The SOFA score was calculated on the 1st and
3rd day in ICU, and APACHE II was calculated on the
initial and the discharge day. Initial arterial blood gases
(ABGs) were recorded. Serum CRP was checked by the
nephelometry method with a BN ProSpecT machine
(DADE Behring). The normal range of CRP is 0–5 mg/L.
Initial and control CRP levels were checked and Δ CRP
was calculated by subtracting control CRP from the
initial value.
Microbiology
Bronchial secretions of patients were collected by deep
tracheal aspiration into the tracheal aspirate tube (if the
patient was intubated). In non-intubated patients spu-
tum was collected into a sputum Petri dish. In the case
of a very low or high fever (<36°C or >38°C) a blood
sample was collected into an aerobic culture media.
Statistical analysis
This was a prospective clinical study concerning progno-
sis. The clinical features, ABGs, SIRS criteria, SOFA
score on the first and third day, initial, control, and Δ
CRP levels, and comorbidities of survivors and non-
survivors were compared. The Mann–Whitney U test
and Student’s t test were used for analysis of continuous
variables with non-parametric and parametric values, re-
spectively. The chi square test was applied for categor-
ical variables (gender, comorbidity, status of IMV and
NIMV) of survivors and non-survivors. The logistical re-
gression model was used for baseline, control, and Δ
CRP levels to predict the relation to mortality. Other
parameters such as nosocomial infection, APACHE II
and SOFA score on the first and third day (believed to
reflect hospital mortality) were also added to the logis-
tical regression model. The area under the curve (AUC)
was used to compare initial and third day SOFA scores,
basal, control, and Δ CRP levels.
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Of the 314 patients included in this study, 208 (66.2%)
were male, and the median age was 64 years (interquar-
tile range (IQR) 51–72). The age and SIRS criteria of the
patients are summarized in Table 1.
Initial APACHE II and SOFA scores, CRP levels,
SOFA scores on the third day, Δ CRP and CRP levels on
the 3rd day are shown in Table 1. The ABG values of
patients on admission to ICU are also summarized in
Table 1. The majority of patients had COPD and their
ABG values demonstrated acute or chronic hypercapnia
with hypoxemia. The location from which enrolled
patients were admitted were the emergency room (118
[37.6%]), inpatient clinic (162 [51.6%]), and other ICUs
(34 [10.8%]). In-hospital days on ICU admission, hospital
and ICU length of stay (LOS), days of mechanical ventila-
tion for invasive (n = 115, 36.6%) and non-invasive (n =
258, 82.2%) mechanical ventilation are shown in Table 1.Table 1 Results of all patients’ characteristics, ICU data and th
All patients (N. 314)
Median (IRQ,25%-%75) M
Age 64 (51–72)
Gender n F/M 106/208
Hospital acquired sepsis % 21.9
ICU severity scores& CRP
APACHE II 1st day 19 (15–24)
SOFA score 1st day 4 (3–6)
SOFA score 3rd day 3 (2–4)
CRP mg/L initial 69.0 (26.9-136.0)
CRP mg/L after 3–5 day in ICU 50.9 (18.4-97.5)
APACHE II 1st day 16.8 (−12.2; 55.1)
Arterial blood gas values
pH values 7.32 (7.25- 7.42)
PaCO2 mmHg 66.0 (44.4-82.0)
PaO2 mmHg 69.9 (54.8-92.7)
Sat O2 % 92.9 (85.4-96.4)
PaO2/FiO2 169.9 (117.8-235.3)
Hospital & ICU days
Pre ICU hospital days 3 (2–8)
Length of stay in ICU 8 (5–13)
Length of stay in hospital 15 (11–21)
Mechanical ventilation
Days of IMV, 6 (3–11)
IMV, % (N) 36.6 (115)
Days of NIV 6 (4–10)
NIV, % (N) 82.2 (258)
ICU: Intensive care unit, CRP: C- reactive protein (N: 0–5 mg/L), APACHE II: acute phy
Assessment, PaCO2: partial pressure of carbon dioxide, PaO2: partial pressure of oxy
invasive mechanical ventilation, NIMV:noninvasive mechanical ventilation. *p valuesHospital acquired sepsis was present in 69 cases (21.9%)
at the time of ICU admission. For 161 patients (51.3%)
diagnostic procedures such as bronchial lavage, deep
tracheal aspiration, blood, and urine cultures were per-
formed to identify the microorganism causing sepsis.
Agents were identified by culture positivity in 63 cases
(20.1%) and P. aeruginosa was the major pathogen iso-
lated (n = 29, 9.2%). The ICU mortality was 14.2%
(n = 45). The clinical features, means of mechanical
ventilation, CRP, APACHE II, and SOFA scores of sur-
vivors and non-survivors are compared in Table 1. The
relation between SOFA scores on the first and third days,
baseline and 3rd day of ICU CRP, and Δ CRP values
and mortality were used to draw ROC curves. For the
SOFA score on the first day AUC: 0.72 ± 0.04, CI: 0.64-
0.81, p < 0.0001; SOFA score on the third day AUC:
0.76 ± 0.05, CI: 0.67-0.86, p < 0.0001; ICU admission
CRP AUC: 0.57 ± 0.05, CI: 0.48-0.66, p > 0.117; CRP one comparison of survivors and nonsurvivors
Survivors (N. 269) Non-survivors (N. 45) p*
edian (IRQ,25%-%75) Median (IRQ,25%-%75)
64 (51–72) 64 (47–71) 0.54
92/177 14/31 0.69
18.2 44.4 0.000
18 (15–23) 23 (20–28) 0.000
4 (3–5) 7 (4–9) 0.000
3 (2–4) 6 (3–8) 0.000
67.2 (26.0 133.0) 91.3 (35.2-161.0) 0.12
44.3 (17.9-88.5) 105.0 (61.0-159.0) 0.000
18.3 (−6.2;55.1) −1.7 (−42.3;53.0) 0.040
7.34 (7.26-7.42) 7.27 (71.8-7.42) 0.017
65.8 (44.9-80.0) 66.6 (43.5-84.4) 0.81
70.6 (55.0-92.0) 65.8 (53.8-97.0) 0.62
93.0 (87.0-96.3) 90.0 (81.9-96.0) 0.17
173.0 (123.3-236.3) 142.0 (97.5-225.0) 0.041
3 (1–7) 4 (2–9) 0.39
8 (5–12) 9 (6–15) 0.19
15 (11–21) 15 (9–21) 0.48
6 (3–11) 7 (4–13) 0.10
31.2 (84) 68.9 (31) 0.000
6 (4–10) 5 (4–9) 0.41
85.5 (230) 62.2 (28) 0.000
siologic and chronic health evaluation II, SOFA: Sepsis related Organ Failure
gen, SaO2: arterial oxygen saturation, FIO2: Fraction of inspired oxygen, IMV:
for comparing the survivors and nonsurvivors data, Mann–Whitney Test.
Figure 1 On the left side, the ROC curve for mortality of the first day of ICU, CRP and SOFA scores were shown. On the right side, the
ROC curves for mortality on the third day, CRP and SOFA scores were drawn.
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and Δ CRP AUC: 0.41 ± 0.05, CI: 0.30-0.50, p < 0.040.
Figure 1 shows the ROC curves on the day of ICU admis-
sion and on the third day of ICU for CRP and SOFA
scores. The third day CRP value was a better predictor
of mortality when compared with the first day CRP.
Sepsis related with nosocomial infection, IMV applica-
tion and the duration thereof, PaO2/FiO2, APACHE II
on admission to ICU, SOFA scores (on admission to
ICU and on the 3rd day), CRP values (initial, 3rd day,
and Δ CRP) were used to form a multi-logistical regres-
sion model. In this model the third day SOFA score,
nosocomial sepsis, and the third day CRP > 100mg/L
were determined to be risk factors for mortality
(Table 2).
Discussion
In this study we have shown that control CRP levels can
be used to predict the mortality of patients with respira-
tory failure due to sepsis and being treated by the sepsis
protocol, as well as the initial APACHE II, and SOFA
scores on the first and third day of ICU (well-known
predictors of mortality).
Sepsis protocols proposed by the Sepsis Campaign
have been successfully used and predicted mortality for
sepsis patients with an initial ICU APACHE II was
32.2%, whereas actual mortality was 14.2%. It has beenTable 2 Mortality risk factors for our patients with sepsis
p OR 95.0% CI
Nosocomial infection 0.001 3.76 1.68-8.40
SOFA score on 3rd day 0.000 1.68 1.41-2.01
CRP > 100mg/L on 3rd day 0.013 2.70 1.23-15.91
OR: Odds ratio; CI: confidence intervals; SOFA scores: Sepsis related organ
failure assessment, CRP: C- reactive protein.suggested that CRP levels could impact on the prognosis
of ICU patients by some studies done in septic dogs and
humans [5-7,14]. Gebhardt et al. [7] declared that the
change in initial and third day control CRP levels was
better for predicting mortality than initial CRP, and a fall
in the third day CRP level demonstrated corrected sur-
vival with 94% accuracy in a study with septic dogs. In
our study, we showed that initial and Δ CRP levels were
not as valuable for predicting ICU mortality in sepsis
patients and 3rd day control CRP was better than initial
CRP values and Δ CRP values, respectively (3rd day CRP
AUC: 0.72, CI: 0.63-0.80; initial CRP AUC: 0.57, CI:
0.48-0.66; Δ CRP AUC: 0.41, CI: 0.30-0.50). These
results differed from the study on dogs by Gebhardt
et al. [7]. Silvestre et al. [4] recently studied the prognos-
tic value of initial APACHE II, SAPS II, SOFA, CRP,
fever, and leukocyte count in 158 sepsis patients. The
AUC (CI 95%: lower-upper limit) was 0.75 (0.67-0.83),
0.82 (0.75-0.89), 0.80 (0.72-0.88), 0.55 (0.45-0.65), 0.48
(0.38-0.58), and 0.46 (0.35-0.56), respectively. They con-
cluded that CRP was not an adequate test for the prog-
nosis of sepsis patients. Initial CRP was not a good
mortality predictor in our study, but control CRP was
found to be as significant as the SOFA score for predict-
ing response to sepsis treatment and prognosis. In an-
other study which looked at the relationship between
CRP levels and mortality in sepsis patients within the
first 24 hours after discharge from ICU, the mean CRP
for non-survivors and survivors was 174 mg/L and 85.6
mg/L, respectively. A high CRP level was indicated to be
an independent risk factor of mortality [15]. In our
study, the CRP level at the time of discharge from the
ICU was not recorded. In addition, we did not follow up
on hospital mortality after ICU discharge. However, in
the present study, after the 3rd-5th day of treatment, the
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survivors (105 mg/L versus 44 mg/L, respectively). In-
stead of initial CRP values, CRP values measured a few
days after admission may be more helpful for physicians
to make judgments on treatment response and sepsis
outcome in the ICU. Pro-calcitonin has also been high-
lighted as an indicator of inflammation due to infection
and there are studies indicating the serum levels of pro-
calcitonin may be a better indicator of sepsis severity
than CRP [16,17]. Pro-calcitonin is much more expen-
sive than serum CRP and we did not use it in this study
for financial reasons. It has been noted that using pro-
calcitonin in sepsis management could increase the val-
idity of the clinical decision since it yields results rapidly
and it has a shorter half-life than CRP (by 19 hours) [5].
SOFA scores on admission to ICU and on the third
day were found to be good predictors of mortality risk
(AUC for SOFA on the 1st day, 0.72 [CI: 0.64-0.81],
SOFA on the 3rd day, 0.76 [CI: 0.67-0.86]). SOFA score
is not as practical or as rapid a test as CRP to evaluate
sepsis severity as it is calculated by adding platelet count,
PaO2/FiO2 ratio, serum bilirubin, creatinine, and the
Glasgow Coma Scale. In our study the 3rd day SOFA
score and the 3rd day CRP value were shown to be risk
indicators for sepsis related mortality when comparing
severity scores. We believe that the 3rd day CRP value
can be used in clinical practice in the ICU to reveal mor-
tality risk and is comparable with the SOFA score when
its level is high on third day after initiation of treatment
for sepsis (> 100 mg/L).
Thus, in this study analyzing risk factors for overall
mortality in sepsis and looking for parameters that influ-
ence mortality (indicated as significant in bivariate ana-
lysis, with logistical regression analysis) a higher SOFA
score on the third day, hospital acquired sepsis, and a
3rd day CRP > 100mg/L were shown to be risk factors
for mortality. The culture positivity for detecting an in-
fectious agent in hospital acquired sepsis was only 20%.
Pseudomonas spp was the most common agent in the
culture results. The low culture positivity was assumed
to be due to ongoing antibioticotherapy at the time of
culture and the initiation of empirical therapy before
collection of the culture specimen. In a previous study
where CRP levels were checked every four days in crit-
ical patients with a 38% rate of culture positivity it was
concluded that a ≥ 50 mg/L fall in CRP levels could be a
good predictor of recovery [18]. In our study there was a
median fall of 18.3 mg/L in Δ CRP in survivors.Conclusions
Sepsis is a preventable pathology. Instead of looking
at high CRP levels on the day of ICU admission due
to sepsis, a CRP level > 100 mg/L on the third day ofICU may be as good a predictor of mortality as a high
SOFA score.
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